Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy. - Harrer, A; Tumani, H; Niendorf, S; Lauda, F; Geis, C; Weishaupt, A; Kleinschnitz, C; Rauer, S; Kuhle, J; Stangel, M; Weber, F; Uhr, M; et al. (Multiple Sclerosis Journal, 2013)